USA VC Funds

Marc Bell Capital Partners, based in Boca Raton, Florida, is a multi-stage investment firm founded in 2002 by Marc Bell, an American financier and serial entrepreneur with a 35-year track record. Bell founded internet data center company Globix Corporation in 1989 at age 21, led it through its 1996 IPO, and sold his position for $120 million in 2000. The firm deploys patient capital across technology and telecommunications — including AI, autonomy, and data centers — as well as aerospace and defense, covering areas such as cybersecurity, electronic warfare, counter-UAS, and space technology, alongside consumer sectors spanning Broadway entertainment and direct-to-consumer brands. Check sizes range from $1 million to $50 million across Seed through Series B rounds, with 86 total investments closed to date. The portfolio's headline achievements include 4 unicorns, 9 IPOs, 16 acquisitions, and more than $10 billion in equity raised across portfolio companies. Marc Bell co-founded Terran Orbital in 2013, a nanosatellite manufacturer and parent of Tyvak that launched 220+ satellites and was acquired by Lockheed Martin for $450 million in August 2024. Other notable outcomes include ICEYE (SAR satellite constellation, unicorn status 2025), Forge Global (acquired by Charles Schwab for $660 million in November 2025), and Vertex (NASDAQ IPO in July 2020 at a $2.72 billion valuation). Additional portfolio companies include Wonolo, Respond, and ARMOUR Residential REIT (NYSE). Marc Bell Capital Partners leads rounds and takes an active approach to building each portfolio company, leveraging Bell's operational background across technology, defense, and entertainment. The firm's sustained focus on aerospace and deep technology — combined with a consumer-facing sleeve — reflects a thesis that transformative companies often sit at the intersection of hardware, software, and real-world infrastructure deployment.

March Capital, established in 2014 and based in Santa Monica, California, is a venture growth firm focused on next-generation technology companies. The firm emphasizes sectors such as enterprise AI, fintech, and commerce enablement, aiming to partner with visionary entrepreneurs and support their growth to market leadership. Notable investments in March Capital's portfolio include CrowdStrike, a leader in cybersecurity; BillDesk, India's premier payments network; and Canva, an online design platform. They have also invested in companies like ActionIQ, a customer data platform, and ASAPP, an AI software company automating customer service. March Capital has seen successful exits from companies such as CarTrade, an online automotive marketplace, and Forescout, a cybersecurity firm. The firm is known for its collaborative approach, working closely with portfolio companies to provide strategic guidance and leveraging their extensive network to drive growth and success. They focus on building concentrated portfolios and doubling down on high-potential investments, ensuring significant impact and returns. March Capital also hosts The Montgomery Summit, a premier technology conference that gathers leading entrepreneurs, investors, and corporate executives to foster relationships and catalyze growth for portfolio companies.

Marcy Venture Partners (MVP), co-founded in 2018 by Shawn "JAY-Z" Carter, Jay Brown, and Larry Marcus, is a venture capital firm based in San Francisco. The firm focuses on investing in consumer and culture-driven companies that emphasize sustainability, inclusivity, accessibility, empowerment, and health & wellness. MVP's approach involves partnering with innovative businesses that are led by exceptional management teams and have strong brand values, outstanding products, and clear growth trajectories​. The firm has raised significant capital, closing its second fund with $325 million, bringing total assets under management to around $600 million. MVP has made investments in companies such as Therabody, Savage X Fenty, and Wheels, demonstrating a keen interest in diverse and impactful sectors. MVP is renowned for its robust support network and hands-on involvement, providing not just capital but also strategic guidance and industry connections to help its portfolio companies scale effectively​.

Maroon Venture Partners Fund is a university-linked venture capital fund based in Amherst, Massachusetts, investing exclusively in early-stage companies connected to the University of Massachusetts Amherst. Founded in January 2017 as the first venture capital fund at UMass Amherst, it was anchored by alumnus Paul Manning (UMass class of 1977, founder of PBM Capital Group, a healthcare-focused private equity firm) alongside UMass Amherst as institutional co-investor. Fund Manager Charlie Johnson, a faculty member at the Isenberg School of Management, oversees day-to-day operations, supported by an investment committee including John Brooks, Nancy Confrey, Mike Masterson, Ameeta Soni, and Steve Willis. Fund I was a $6 million vehicle that deployed approximately $5 million across 13 companies led by UMass faculty, students, and alumni, completing its investment period in 2023. Typical check sizes are $100,000 to $300,000, often representing a company's first outside equity capital. Fund II launched in January 2024 with $3.2 million in commitments against a $5 million target, backed by Manning, UMass Amherst, and additional alumni LPs. The fund operates on a ten-year harvest horizon. Sectors served include biotech, diagnostics, advanced materials, and food and beverage. Portfolio companies include Myrias Optics (wafer-level metaoptics, which raised a $2.1 million Seed 1 round in January 2026), 88 Acres (allergen-friendly foods, founded by Nicole Ledoux, UMass class of 2001), florrent, Latde Diagnostics, and HasenTech. The fund's narrow mandate — backing only ventures with genuine UMass Amherst roots — gives it privileged early access to the university's research pipeline and entrepreneurial ecosystem. Portfolio companies benefit from faculty expertise, the university's laboratory infrastructure, and a growing alumni investor network that has grown with each successive fund.

MarsBio is a Los Angeles-based venture capital fund that focuses on investing in pre-seed and seed-stage biotech startups. The firm specializes in biosciences and frontier technologies, targeting innovations in healthcare, therapeutics, synthetic biology, and the future of food. With check sizes ranging from $250K to $500K, MarsBio supports startups that push the boundaries of biology, using it as a tool for manufacturing and sustainable solutions. Their portfolio reflects an interest in companies working on immunology, oncology, neuroscience, and bio-enabling technologies, such as research tools and bioelectronics. Co-founded by Rob Rhinehart, best known for creating Soylent, MarsBio aims to back visionary founders with disruptive ideas. The firm emphasizes its support for entrepreneurs tackling complex problems, particularly those related to sustainable food supply chains and novel healthcare solutions. MarsBio’s strategy is to engage deeply with founders at the earliest stages, helping them scale innovative solutions that have the potential to redefine industries. MarsBio primarily invests in U.S.-based companies and leverages its expertise and network to drive transformational progress in biosciences. They’re especially drawn to startups that are pioneering new technologies that could shape the next era of healthcare and sustainable living.

Marshall Ventures is a micro-venture capital fund and business advisory firm based in Owensboro, Kentucky, founded in 2015 by John Marshall Moore, a fourth-generation business owner with a background in analyzing, strategizing, and capitalizing businesses. The Marshall Venture Fund is a $2 million vehicle backed by 16 local investors, with Jamie Johnson serving as Director of Business Development and Fund Administrator. The firm concentrates exclusively on early-stage growth businesses in Owensboro and Western Kentucky, preferring companies that have already developed a minimum viable product and are generating revenue. Typical investment sizes range from $100,000 to $300,000. The portfolio of five companies spans healthcare technology, clean energy, software, and education. The first local investment was $200,000 into Gryphon Environmental, a machinery and environmental services company, in September 2017. Prior investments include Liberate Medical (a Louisville medical device company, $100,000 in September 2016), Nectar Technologies (a Henderson, Kentucky clean coal technology company, $290,000 in July 2016), Giblib (an educational software and medical education platform), and Schedule It (financial software). Beyond capital, Marshall Ventures provides business advisory services to its portfolio and hosts events such as Pitch Day to connect local entrepreneurs with investors. The firm operates at a deliberate, regional pace rather than pursuing high-frequency deal flow, reflecting a commitment to building economic development capacity across Western Kentucky rather than maximizing returns through volume. No exits have been publicly reported to date.

Martin Ventures is a Nashville-based single-family office and healthcare-focused venture capital firm founded in 2009 by Charlie Martin, a veteran healthcare executive with more than 50 years of experience operating large, complex healthcare systems. Unlike traditional venture funds, the firm invests its own capital rather than managing external LP money, enabling a patient, long-term investment approach unconstrained by fund cycles. The firm's mandate covers healthcare technology, healthcare services, and tech-enabled healthcare services that optimize provider businesses, develop innovative care models, and empower consumers — explicitly avoiding medical devices and biotech requiring regulatory approval. Martin Ventures typically writes $1 million to $3 million checks into companies with $2 million or more in ARR and strong growth trajectories, and leads rounds. Across 108 total investments, the portfolio has produced 2 unicorns, 1 IPO (Amwell), and 22 acquisitions including Ovia Health and Cedar. Recent investments include ArcheHealth ($6.7 million seed in June 2025) and Harbor Health (clinics and outpatient care, September 2025). Martin Ventures also serves as the primary funding source for ROND Capital, a private equity firm, and Medical Properties of America, a healthcare REIT. The firm operates a shared-service advisory company and a boutique consulting practice that provide operational support and mentoring to portfolio entrepreneurs alongside capital. Charlie Martin's five decades of healthcare operating experience gives portfolio founders direct access to a leader who has built and led institutions across the healthcare system — a resource that pure financial investors rarely offer. The firm's deliberate focus on revenue-generating, technology-enabled healthcare companies reflects a disciplined effort to back companies at the moment they are ready to scale commercially rather than betting on regulatory or clinical outcomes.

Marubeni Corporation, founded in 1858 and incorporated in 1949, is a prominent Japanese general trading company headquartered in Tokyo. The company operates across numerous sectors including lifestyle, IT solutions, food, agriculture, chemicals, metals and mineral resources, energy, power, infrastructure projects, aerospace, shipping, finance, leasing, real estate, and industrial machinery. Marubeni is committed to sustainability and innovation, aiming to create solutions that foster positive societal impact while maintaining financial performance. This commitment is reflected in their investments and operations across diverse industries worldwide. The company's philosophy of "Fairness, Innovation, and Harmony" drives its vision for a sustainable and prosperous future. The company has a robust global network with over 4,300 employees and numerous subsidiaries and affiliates, highlighting its significant presence and influence in the international market. Marubeni's extensive operations and strategic investments underscore its role as a key player in global trading and investment.

Marubeni Ventures is the corporate venture capital arm of Marubeni Corporation, one of Japan's major integrated trading and investment conglomerates. Founded in 2019 and based in Tokyo's Chiyoda City, the firm invests across a wide range of sectors without limiting itself to specific industries, drawing on the Marubeni Group's global network, operational know-how, and industry expertise to generate strategic value for portfolio companies beyond capital alone. The team of five — including one partner — operates across Japan and the United States, primarily targeting Series A rounds with a preference for minority stakes. The portfolio comprises 18 investments across AI, e-commerce, hardware and robotics, fintech, and food technology. The headline holding is GrubMarket, a tech-enabled food delivery and distribution company that achieved unicorn status in 2021; Marubeni participated in its $60 million Series D in October 2020 alongside BlackRock and GGV Capital. Other portfolio companies include Floadia (semiconductor flash memory IP, founded by former Renesas engineers), D-ID (AI-powered privacy and video solutions), noin (Japanese cosmetics e-commerce), LPixel (AI decision and risk analysis, most recent investment June 2025), LinkWiz (industrial robot automation), Bumper International (automotive fintech), and River. Marubeni Ventures creates value by opening Marubeni's global distribution channels to portfolio companies, facilitating partnerships with Marubeni business units, and supporting proof-of-concept deployments that leverage the conglomerate's existing customer relationships across energy, food, infrastructure, and industrial markets. This access to one of Japan's largest trading networks represents a meaningful advantage for startups seeking commercial traction in Asia-Pacific and beyond.

MassMutual Ventures (MMV) is a global venture capital firm that invests in a range of sectors, including enterprise software, cybersecurity, financial technology, digital health, and climate technology. Founded in 2014 and based in Boston, MMV also has offices in London and Singapore. The firm manages over $1 billion in investment capital and focuses on accelerating the growth of its portfolio companies by providing capital, connections, and strategic advice. Notable investments by MMV include Prove, a leader in digital identity solutions; Daye, a gynecological health startup; and Griffin, a developer-friendly Banking as a Service platform. The firm's portfolio spans across various stages of investment, from seed to growth stage, with typical check sizes ranging from $100,000 to $5 million. In 2022, MMV launched a $100 million Climate Technology Fund to invest in early and growth-stage companies addressing climate change. This fund aims to support 15 to 20 companies developing solutions to mitigate, measure, and manage climate change impacts, further expanding MMV's commitment to sustainable innovation​. The team at MMV includes experienced investors, former entrepreneurs, and operators, such as Doug Russell, the Managing Partner and Head of MMV, and Ryan Collins, the Managing Partner for Europe and APAC. Their deep industry expertise and extensive network help portfolio companies scale and succeed in competitive markets.

MassVentures, established in 1978 as the Massachusetts Technology Development Corporation, is a venture capital firm dedicated to supporting early-stage technology startups in Massachusetts. With a mission to bridge the capital gap for startups, MassVentures has invested $91.9 million in 152 companies from its inception through June 2019. The firm focuses on diverse sectors including life sciences, robotics, and advanced manufacturing, and typically makes initial investments of $250,000 to $500,000. Notable investments include Battery Resourcers, Inkbit, and Pison. Additionally, MassVentures administers the Small Business Innovation Research Targeted Technologies (SBIR-TT) grant program, which has awarded $22.1 million to 79 companies since 2012. This program supports the commercialization of innovations emerging from academic research and small businesses, fostering technological advancement and job creation in the state. MassVentures is led by an 11-member board of directors, predominantly from the private sector, and operates with a small team based in Boston. The firm not only provides financial support but also strategic guidance and operational expertise to help startups scale successfully. Through its investments and grant programs, MassVentures plays a crucial role in the growth of Massachusetts' innovation ecosystem, aiming to enhance the state's economic development by nurturing high-potential startups.

Matador Ventures Capital is a Delaware-based early-stage venture capital firm that backs visionary founders with bold ideas across AI, fintech, deep tech, automation, space, healthcare technology, B2B software, and gaming. The firm is SEC-registered as an Investment Adviser (CRD# 326016) and also operates a syndicate on AngelList, enabling it to co-invest alongside a network of high-net-worth individual equity partners and institutions. The fund manager has actively engaged in more than 50 deals across technology and consumer industries spanning North America and Europe. Matador invests from pre-seed through Series A, with typical check sizes in the range of $100,000 to $1 million. The firm focuses on high-growth potential companies led by founders with transformative ideas. Recent portfolio activity includes ChatBlu (business productivity software, July 2025). The firm is a newer entrant in the early-stage landscape, and broader portfolio composition and fund size are not publicly disclosed. The firm's investment philosophy centers on identifying visionary entrepreneurs and providing the capital needed to move from groundbreaking idea to viable business. By investing its own capital alongside a curated group of individual and institutional co-investors, Matador Ventures aims to give founders both the financial backing and the network access needed to accelerate growth from inception.

Matchstick Ventures, founded in 2013 and based in Boulder, Colorado, and Minneapolis, Minnesota, focuses on early-stage investments, particularly at the seed stage. The firm targets high-growth technology companies in underserved startup ecosystems, especially in the Rockies and North. Their portfolio includes notable investments such as Upsie, which offers affordable and reliable warranties for electronic devices; StackHawk, which provides tools for developers to incorporate security testing into their applications; CometChat, which enables businesses to add voice, video, and chat capabilities to their apps and websites; and Inspectorio, which enhances transparency and efficiency in the global supply chain. Typically, Matchstick Ventures invests in seed and early-stage companies with initial check sizes ranging from $500,000 to $1.5 million. The firm is known for its hands-on approach, offering extensive support to its portfolio companies through strategic guidance, networking opportunities, and operational assistance. Led by partners Ryan Broshar and Natty Zola, Matchstick Ventures is deeply embedded in local startup communities, actively contributing to their growth and development through various initiatives and collaborations.

Material Impact, founded in 2015 by Adam Sharkawy and Carmichael Roberts, is a venture capital firm based in Boston, Massachusetts, that focuses on transforming material science innovations into impactful real-world applications. The firm is dedicated to addressing large-scale problems related to food, water, sustainable manufacturing, transportation, mobility, and healthcare through its investments in deep tech companies. Material Impact's portfolio includes notable companies such as DetraPel, Bloomer Tech, Folio Photonics, and Nohbo. These investments span a range of industries, including specialty chemicals, healthcare monitoring equipment, IT storage, and personal products. The firm’s hands-on approach to building companies involves working closely with founders to guide them through critical growth stages​. In 2023, Material Impact announced its $352 million Fund III, aimed at continuing its mission to support early-stage startups that leverage material science to solve pressing global challenges. This new fund allows Material Impact to take larger ownership stakes while maintaining its active role in company development. The firm's commitment to diversity and impact is reflected in its alignment with the United Nations Sustainable Development Goals and its diverse leadership team​. For entrepreneurs interested in partnering with Material Impact, the firm values innovations that have strong scientific foundations and the potential to address significant human needs. Material Impact provides not only capital but also strategic and operational support, often embedding its team members within portfolio companies to ensure their success.

MATH Venture Partners is a Chicago-based early to growth-stage venture capital firm founded in 2014 by Mark Achler and Troy Henikoff. Managing Directors Troy Henikoff and Dana Zachgo Wright lead a team of six including four partners. The firm closed its second fund (MATH II) at $46 million in April 2019. Collectively, the MATH team has built, scaled, and sold businesses worth more than $7 billion and has partnered with more than 200 companies as investors. The firm invests $1 million to $5 million per deal, leading rounds across Seed, Series A, and Series B stages. MATH focuses on teams building companies with an unfair advantage in customer acquisition — seeking founders for whom customer acquisition is embedded in their core DNA. Key sectors include B2B and B2C software, marketplaces, e-commerce, SaaS, tech-enabled services, hardware-enabled software, and IoT, with a primary geographic focus on the Midwest and other under-capitalized US markets, plus broader coverage of the US and Canada. Across 73 portfolio companies, the firm has produced 2 unicorns — Acorns (micro-investing) and REEF (logistics and real estate) — along with 14 acquisitions and 13 exits. The latest exit was Mission Control in September 2024. Other notable portfolio companies include BuiltIn (tech job platform), SpotHero (parking marketplace), Chowly (restaurant technology), EatStreet (food delivery), ChefHero, Cardflight, ClearCOGS, and Pie Systems (Series A, November 2025). MATH operates as a hands-on investor, offering portfolio companies access to the team's collective network of operators, customers, and executives accumulated across decades of building companies in the Midwest and beyond. The firm's conviction that customer acquisition discipline separates durable businesses from one-hit products shapes both its selection process and its post-investment involvement.

Matr (matter) Ventures is a New York City-based venture capital firm founded in 2021 that backs underestimated founders through capital and connectivity. General Partner Giselle Melo — a former founder, tech, and capital markets leader with a 13-year track record and one exit — and Partner Chris Lynch lead a team of seven operating across Canada and the United States. The firm's founding philosophy is rooted in hip hop principles and the conviction that culture drives technology rather than the other way around, shaping both the companies it seeks and the founders it champions. Matr invests $250,000 to $1 million at late seed, Series A, and Series B stages, targeting deep tech and digital infrastructure companies specializing in applied AI and machine learning, robotics automation, semiconductor solutions, computer vision, and edge computing. Priority sectors are energy, health, cybersecurity, and fintech and climate. The fund completed its initial close and was accepting new investors through the first quarter of 2024. A curated network of more than 400 advisors provides substantive engagement with portfolio companies rather than nominal advisory relationships. Portfolio company details are not publicly disclosed. Matr specifically targets untapped markets, undervalued opportunities, and companies led or co-led by culturally diverse or women founders. Advisory board members include Mark Castleman and Jim Estill. Giselle Melo also serves on the CIX Summit advisory board. The firm's combination of deep tech focus, diversity mandate, and a 400-person advisor network positions it as an access-oriented fund designed to surface deal flow and talent that conventional VC pipelines underserve.

Matrix Partners is a powerhouse in early-stage venture capital, boasting over four decades of experience and $4 billion in assets under management. Their portfolio spans transformative startups like Canva, Afterpay, Oculus, and Hubspot, among 65+ IPOs and 110+ acquisitions. With offices in San Francisco and Boston, Matrix invests globally, focusing on the U.S., India, and China. Their sweet spot is in sectors like AI, fintech, digital health, and B2B SaaS. Matrix is known for its commitment to backing founders from seed through Series A, providing checks ranging from $100K to $1M. They emphasize patience, nurturing relationships with company builders and former founders, helping them scale effectively. While they often lead rounds, Matrix also co-invests, partnering with top VCs like Y Combinator and Andreessen Horowitz. Key team members include Pranay Desai and Paul Sherer in San Francisco, and they maintain a reputation for being hands-on, leveraging deep expertise across diverse tech-driven industries. Entrepreneurs seeking funding should approach Matrix with a clear vision for scalable innovation, as the firm is laser-focused on high-impact, technology-driven ventures.

Matterwave Ventures, established in early 2022 from the former btov Industrial Technologies team, focuses on investing in early-stage European industrial hardware and software companies. Headquartered in Munich, Germany, Matterwave aims to empower startups to become global leaders in the industrial sector. Their €130M Matterwave Industrial Technologies II fund backs 20-25 companies, with initial investments ranging from €1M-4M and up to €10M in follow-on rounds. Matterwave's investment strategy prioritizes automation, digitalization, and resource efficiency within industrial value chains. They target technologies in enterprise automation, frontier tech, production optimization, and sensor-powered solutions. Notable portfolio companies include TVARIT, which specializes in AI for sustainable manufacturing, and Orcan Energy, focusing on industrial heat capture. Led by a team with over 50 years of combined venture capital experience, Matterwave Ventures leverages deep industry knowledge and strong market connections to support its portfolio companies. The team includes experts with backgrounds in engineering, physics, and technology commercialization, ensuring they provide comprehensive strategic guidance. Matterwave Ventures emphasizes sustainability and resource efficiency, aligning their investments with the EU's Sustainable Finance Disclosure Regulation. This commitment reflects their broader goal of enhancing Europe's industrial competitiveness while addressing environmental challenges​.

Maven Ventures is a seed-stage venture capital firm specializing in consumer software startups. With a notable track record, Maven has backed major successes like Zoom, Cruise, and Epic!, achieving significant exits and IPOs. Founded in 2013, the firm has maintained a focused strategy, supporting around 50 high-potential startups with investments typically ranging from $750K to $1M. The firm is keenly interested in emerging consumer trends and technologies, investing in sectors like digital health, autonomous vehicles, fintech, and AI-driven solutions. Geographic focus primarily includes the United States, particularly Silicon Valley, but Maven also invests in global opportunities. Maven Ventures' strategy is highly selective, with a small team providing hands-on support to a concentrated portfolio. The team, led by seasoned investors like Jim Scheinman, focuses on building deep relationships with founders, offering critical guidance on marketing, product development, and go-to-market strategies. Recent investments include startups like Hello Heart, which provides mobile solutions for heart health, and Wildtype, a company pioneering lab-grown seafood. The firm has a proactive approach to diversity, supporting a range of women-led and minority-led startups. Maven Ventures prefers to be approached through a well-articulated pitch that demonstrates a strong market need and scalable solution. With a reputation for nurturing bold founders and transformative ideas, Maven Ventures remains a prominent player in the VC landscape, consistently driving innovation and impactful growth in the consumer tech sector​.

Maverick Ventures is the venture capital arm of Maverick Capital, a multi-billion dollar hedge fund platform managing approximately $12.5 billion in AUM. Founded in 2015 in San Francisco, Maverick Ventures operates as an evergreen fund structurally integrated with the hedge fund platform, giving portfolio companies access to hedge-fund-grade analysts and public company networks that conventional VC firms cannot match. By March 2025, the firm had raised over $240 million for its fourth vintage — led by Kindred Capital with Y Combinator, Rebel Fund, and Concept Ventures joining — bringing total capital raised to $855 million and AUM to $1.4 billion. Managing Partner David Singer, a repeat founding CEO of three public companies, leads a deliberate five-person investing team that backs only a select number of companies per year to enable deep engagement with each founder. The firm focuses on healthcare innovation and enterprise AI, investing from Seed through Series C and beyond with check sizes typically between $3 million and $50 million. Maverick leads rounds. Across 83 total investments, the portfolio has produced 10 unicorns, 12 IPOs, and 37 acquisitions. Notable exits include Hims and Hers (seed investor through its 2021 IPO), BioCatch (sold to Permira for $1.3 billion in 2024), Coupang, One Medical, and Tata 1mg. Recent investments include Oula Health ($28 million Series B co-led, December 2024) and Garner (healthcare technology, February 2026). Approximately 30 percent of fund capital comes from Maverick partners and employees — the largest single LP — a structural feature that aligns the partnership's own capital with founder outcomes. Maverick's integration with a mature public markets platform allows it to support companies from first institutional check through post-IPO holding, providing continuity of partnership that few venture platforms can offer.

Maverick Ventures (Israel) is a Tel Aviv-based venture capital firm founded in 2013 by Yaron Carni, who previously founded the Tel Aviv Angel Group and sold the first Israeli company acquired by Google. Managing Partner Michel Abadi leads a team of 11 including three partners. The firm operates as a multi-stage platform across six funds, including Maverick Ventures Israel III, collaborating across private and public strategies to support companies from inception through IPO. A notable structural feature: 30 percent of the firm's capital is committed by Maverick partners and employees, representing the largest single LP position in the fund. Maverick invests $1 million to $3 million at Seed through Series B stages and leads rounds. The firm is sector-agnostic except for explicit exclusions covering crypto and blockchain, medical devices, chips and semiconductors, and ad tech. Since early 2023 the investment focus has centered on AI-adjacent and infrastructure-supporting companies. Across 83 total investments, the portfolio has produced 2 unicorns — Taboola and Redis — along with 2 IPOs and 16 acquisitions across 21 exits. Recent investments include Hirundo ($8 million seed for AI optimization and machine unlearning, led by Maverick, June 2025), Commure (healthcare enterprise systems, June 2025), and Wild Moose (Seed, October 2025). Other notable portfolio companies include Vendi AI, Artemis Health, and Aptible (exit November 2025). The firm's name derives from the Hebrew word meaning 'to shine,' reflecting an investment culture oriented toward conviction and differentiation. Maverick's willingness to lead from seed through late stage, combined with the large GP and team co-investment, aligns the partnership's financial interests tightly with those of portfolio founders.

Maveron, a consumer-only venture capital firm, was founded in 1998 by Dan Levitan and Howard Schultz, the visionary behind Starbucks. The firm focuses on early-stage investments in transformative consumer brands. With a keen understanding of consumer behavior and market trends, Maveron has built a diverse portfolio that includes notable companies like Allbirds, Everlane, and Zulily. Maveron operates with a mission to back entrepreneurs who aim to change how people live, work, learn, play, eat, and stay well. Their investments span various consumer sectors such as health and wellness, e-commerce, and food innovation. Some of their prominent exits include eBay, Trupanion, and Potbelly Sandwich Works. The firm recently raised $225 million for its eighth fund, continuing its legacy of identifying and supporting early-stage consumer startups. Maveron's team, led by experienced partners like Dan Levitan and Jason Stoffer, brings deep industry knowledge and a commitment to fostering long-term partnerships with entrepreneurs.

Max Ventures, founded in 2013 by Ryan Darnell and Sophie Stenbeck, is a dynamic seed-stage venture capital firm based in New York. Notable for its early investments in companies like Boxed, ZoomCar, Button, and Drone Racing League, Max Ventures focuses on consumer tech and health-tech startups. The fund targets North American markets and emphasizes investing in founders with unique consumer insights and relentless drive. Max Ventures typically makes initial investments ranging from $750K to $1M, often leading the rounds. Their strategy involves a hands-on approach, leveraging their extensive network to support portfolio companies in achieving significant growth. The fund is particularly interested in startups within the fashion/beauty, food and beverage, internet and web services, real estate, and software industries. The team, including key figures like Managing Partner Matthew Weinberg, prides itself on its ability to identify and nurture innovative talent. Startups looking to approach Max Ventures should focus on demonstrating strong consumer insight and a clear execution plan. Recently, the firm has been active with investments like UnityAI in healthcare technology, showcasing their ongoing commitment to pioneering advancements in tech.

Max Ventures and Industries Limited (MVIL) is a publicly listed Indian company on the NSE and BSE exchanges, part of the $3 billion Max Group conglomerate founded by Analjit Singh in 1985 and headquartered in New Delhi. MVIL serves as the holding company for Max Estates (real estate development), Max Speciality Films (packaging and labeling films), MAX Learning, and MAX I., its investment subsidiary. Under CEO and Managing Director Sahil Vachani, the company generated revenue of approximately 1,200 crore rupees in FY2024. The investment arm has made approximately 22 venture investments across the United States, India, Sweden, and other markets, spanning enterprise applications, retail, consumer, healthcare, and digital commerce. Check sizes have typically been in the $1 million to $3 million range at Seed through Series B stages. The portfolio has achieved significant outcomes including one unicorn — K Health, an AI-powered primary care platform that achieved unicorn status in 2021, with MVIL backing the company since seed stage — and two IPOs: Nykaa (listed on the BSE and NSE in November 2021 at a $7.14 billion market capitalization) and Avnet (NYSE). Five portfolio companies have been acquired. MVIL's investment approach reflects its position as the venture and innovation arm of a diversified conglomerate, with a board that includes founder Analjit Singh, Arvind Aggarwal, Bishwajit Das, Tara Singh Vachani, and Sahil Vachani. The fund identifies sunrise sectors where MVIL's industrial and consumer network can provide portfolio companies with market access and operational credibility beyond what a purely financial investor could offer.

Maxfield Capital is a venture capital firm specializing in early-stage investments, focusing on IT and internet sectors. Established in 2013 by Alexander Turkot, the firm has a global presence with offices in New York, Tel Aviv, and Moscow. Maxfield Capital aims to bridge the gap between high-quality engineering and commercial execution, helping startups scale globally. The firm's investment focus includes sectors such as e-health, digital lending, data protection, mobility, e-education, marketplaces, and cloud computing. Maxfield Capital typically invests in companies that are beyond the seed stage, preferring those with more advanced development​. Alexander Turkot, the founder and managing partner, brings extensive experience from his background in IT, engineering, and project management, including significant roles at IBM and the Skolkovo project. Other key partners include Oleg Koujikov and Alexander Lazarev, who manage operations across various regions.

Mayfield is a renowned venture capital firm founded in 1969, with a focus on early-stage investments. The firm is based in Menlo Park, California, and has a strong presence in the U.S. and India. Mayfield has made significant contributions to the tech industry, backing over 852 companies, including notable names like Lyft, Couchbase, and Poshmark. Mayfield’s portfolio showcases a diverse range of sectors, emphasizing artificial intelligence, enterprise software, consumer tech, semiconductors, and human and planetary health. Some of their standout investments include Unstoppable Domains, Amagi, and BigPanda, which have grown into unicorns under their guidance. The firm has also successfully shepherded companies to IPO, such as Lyft and Couchbase, and facilitated numerous high-profile acquisitions. The firm operates with a "people-first" investment philosophy, aiming to partner with visionary entrepreneurs from inception through growth stages. They typically invest in Seed, Series A, and Series B rounds, providing not only capital but also strategic support and mentorship. Mayfield's investment team includes seasoned partners like Navin Chaddha and Ursheet Parikh, who bring extensive industry experience and a track record of successful exits. Mayfield's investment strategy involves close collaboration with founders, focusing on building enduring companies that can achieve market leadership. Founders looking to connect with Mayfield should highlight their innovative solutions and potential for significant impact, aligning with the firm’s mission to back transformative technologies.

MariaMazarine Ventures is a Chicago-based venture capital firm dedicated to addressing the global water crisis through technology. Founded in 2018, Mazarine exclusively invests in early-stage startups that are developing innovative solutions for managing water and wastewater-related risks across various industries. These sectors include agriculture, aquaculture, climate tech, and industrial applications, among others. The firm operates multiple funds, each with a unique focus. Fund II, for instance, targets companies with proven commercial traction—often nearing $1 million in annual sales—and intellectual property rooted in fields like chemistry, data science, and materials science. Mazarine typically leads seed and early Series A rounds, cutting checks between $25,000 and $500,000, and often continues to support its portfolio companies through follow-on investments. Mazarine’s investment strategy is centered on mitigating critical risks—such as public health, environmental protection, and business continuity—posed by water scarcity and quality issues. The firm’s approach extends beyond financial backing; it leverages a network of experienced operators and co-investors to provide strategic support, helping startups scale and achieve meaningful impact. The leadership team, including co-founders John Robinson, Pete Nassos, and Anders Hallsby, brings decades of experience in commercializing water and wastewater technologies. Mazarine’s rigorous focus on ESG (Environmental, Social, and Governance) metrics underscores its commitment to not only financial returns but also substantial environmental and social impact​. wll do on Thu

in 2001, MBVP primarily focuses on medical device startups, particularly those addressing musculoskeletal diseases. Notable investments include startups acquired by industry giants like Johnson & Johnson, Medtronic, Smith + Nephew, Zimmer Biomet, and Wright Medical (now part of Stryker). MBVP's strategy emphasizes providing not just capital but also strategic direction, leveraging their deep industry connections and expertise. They typically invest at all stages of development, ensuring that startups have the support they need from inception through to exit. The firm is known for its active role in the Musculoskeletal New Ventures Conference, a testament to its leadership in the sector. The team is led by co-founder Gary Stevenson, whose background includes significant roles in healthcare investment banking, equity research, and general management at Abbott Laboratories. Gary's comprehensive experience and his educational background, including an MBA from Northwestern University's Kellogg School of Management, underscore the firm's robust leadership. MBVP prefers to be approached by startups with a clear, compelling value proposition in the life sciences sector. They are known for writing substantial checks and often lead investment rounds. Their involvement in over 50 startups highlights their active investment approach and commitment to advancing medical innovations​.

MBX Capital, established in 2015, is a venture capital firm headquartered in Claymont, Delaware. The firm specializes in early-stage investments within the healthcare and life sciences sectors, focusing on pre-seed, seed, and Series A rounds. MBX Capital has a robust portfolio that includes companies like Luna, Concert Health, Koneksa Health, Atlas Labs, and Buoy Health​. Notable recent investments by MBX Capital include Vivodyne, which raised $38 million in November 2023, and Macro Trials, which secured $6 million in June 2023. These investments underline the firm's commitment to advancing biotechnology and clinical trials​ (PitchBook)​. Additionally, MBX Capital led a $10.7 million Series A financing for Contraline, supporting the development of innovative medical technologies​​. The firm's co-founders, Gurdane Bhutani and Zeshan Muhammedi, lead a team that provides hands-on support to portfolio companies, leveraging their expertise and extensive network to drive growth and innovation​​. MBX Capital's strategic approach and active involvement make it a key player in the venture capital landscape for healthcare and life sciences startups.

McNamara Family Ventures (MFV) is a Brentwood, Tennessee-based family investment office providing venture and growth capital exclusively to companies in the healthcare industry. The firm was founded by Kevin McNamara, a veteran healthcare finance executive who served as CFO of HealthSpring Inc. from 2005 to 2009 and oversaw the company's NYSE listing in February 2006. HealthSpring was subsequently acquired by Cigna Corporation for $3.8 billion in 2012, establishing McNamara's track record as an operator with direct experience in building and exiting a scaled healthcare services company. MFV targets Series A and Series B stage investments with check sizes typically in the $1 million to $10 million range. The firm invests across the broader healthcare sector, drawing on McNamara's operating experience spanning healthcare, business services, retail, and manufacturing, as well as significant private equity experience. He holds a BS from Virginia Commonwealth University, an MBA from the University of Richmond, and is a CPA. He currently serves on the boards of Tyson Foods (NYSE), Luminex Corporation, and Leon Medical Centers. The only publicly documented investment is DigiScript (recapitalization, September 2006). MFV positions itself as an active capital provider rather than a passive financial investor, helping portfolio management teams with business plan development, strategic planning, tactical execution, mergers and acquisitions, strategic partnerships, and key talent recruitment. The firm operates quietly within the Nashville healthcare ecosystem, prioritizing a focused mandate over portfolio breadth.

MDC Ventures (formerly KBS Ventures) was the corporate venture capital arm of MDC Partners, a global advertising and marketing services holding company traded on NASDAQ under the ticker MDCA. Founded in 2010 in New York City, the fund invested in early-stage marketing technology companies with the stated aim of transforming the global marketing landscape. Managing Partner Joshua Engroff led a lean team of two, investing $1 million to $5 million per deal with approximately two to six deals annually. The fund operated one vehicle — MDC Capital Partners Ventures — and made 49 total investments across its lifetime. The portfolio produced 10 acquisitions. The most notable exit was SocialFlow, a social media management and content optimization platform acquired by Piano in February 2022. Other portfolio companies and exits included Dextro (computer vision AI), awe.sm (social analytics), PlaceIQ (location intelligence), Yieldbot (intent-based advertising), and Serena and Lily (home design). Investment categories spanned advertising and marketing technology, data and analytics, AI, VR and AR, and e-commerce. MDC Partners itself merged with Stagwell Marketing Group in August 2021 to form Stagwell Inc. (NASDAQ: STGW), a $2.7 billion-plus revenue digital marketing services company. MDC Ventures is now permanently closed, with its most active investment period spanning 2010 to 2019. The fund's legacy is a concentrated portfolio of martech companies that benefited from privileged access to MDC Partners' network of agencies, clients, and media relationships during the rapid commercialization of digital and programmatic advertising.

Media Technology Ventures is a Dallas-based private equity and venture capital firm that invests in radio and television spectrum, media technologies, and software development. The firm has operated across at least five fund iterations, including Media Technology Ventures V B LP raised by Mediatech Administrative V LLC. Founders Andrew Escher, John Zozzaro, Paul O'Brien, and Ted Cohen built the firm around a cross-platform presence spanning traditional broadcast infrastructure and emerging media technology. Paul O'Brien also runs a related entity, MediaTech Ventures, a global venture development group that operates incubator cohorts and educational programs for media-focused startups. The firm has made approximately 35 investments across media and entertainment, software, advertising and marketing technology, communications, and gaming, with 22 recorded exits reflecting a high portfolio turnover rate. Notable portfolio companies include Eveo (Series A). Investment activity appears concentrated in the early 2000s, with no publicly recorded deals in 2024 or 2025, suggesting the primary fund vehicles are fully deployed or in harvest mode. A related entity, TK MediaTech Ventures, based in New Mexico and founded by Jim Ward and Stewart Alsop, received $15 million from the New Mexico State Investment Council for seed and early-stage investing in US-based media technology spanning film, music, gaming, public relations, advertising, and ad tech. The firm's investment thesis has historically bridged legacy spectrum infrastructure with next-generation media software and advertising technology, positioning it at the convergence of broadcasting, digital distribution, and content monetization across multiple fund cycles.

MedImmune Ventures was the wholly-owned corporate venture capital arm of AstraZeneca, founded in 2002 and headquartered in Gaithersburg, Maryland. The fund managed $400 million in an evergreen structure following AstraZeneca's commitment of an additional $100 million in November 2011. Senior Managing Director Ron Laufer led a team of three partners. Since 2009, the fund operated as a true evergreen vehicle, recycling proceeds from liquidated investments into new portfolio companies rather than returning capital to LPs on a fixed timeline. MedImmune Ventures focused on equity investments in private companies developing small and large molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging, and healthcare IT related to pharmaceutical product discovery and commercialization. Therapeutic areas covered infectious diseases, cancer, inflammatory diseases, cardiovascular and metabolic disorders, pain and central nervous system conditions, and gastrointestinal disease. The fund leads rounds. Across approximately 65 investments, the portfolio produced 4 IPOs and 11 acquisitions. Notable holdings include G1 Therapeutics (MedImmune led a $12.5 million Series A in October 2013 and the company later completed a $105 million Nasdaq IPO), Melinta Therapeutics, Astria Therapeutics, and Xencor. The fund also co-led a financing round in NeuProtect Pty Ltd, an Australian cardioprotectant company, alongside Starfish Ventures. MedImmune Ventures is now permanently closed and liquidated. During its active years, the fund served a dual mandate: generating financial returns for AstraZeneca while sourcing strategic intelligence about emerging biotech platforms across areas aligned with the parent company's therapeutic priorities. The evergreen structure allowed for patient capital deployment matched to the long development timelines of biopharmaceutical companies.

Medingenii Capital, based in Houston, Texas, is a venture capital firm specializing in early-stage investments in healthcare, medical devices, healthtech, and life sciences. With a clear focus on disruptive solutions addressing critical challenges in these fields, the firm leverages its deep connections within the Texas Medical Center ecosystem and a global network of co-investors and industry leaders to scale startups for growth and successful exits. Notable portfolio companies include Vitls, Ucardia, and Forest Devices, all of which innovate in life sciences and medical technology. Medingenii’s investment strategy targets healthtech startups, particularly those advancing genomic testing, patient engagement, and medical devices. The firm prefers to engage early, often leading or co-investing in rounds. Their average check size typically hovers around $1.5M. The leadership team, including key figures like Greg Campbell, Diane Yoo, and Eddie Patton, brings decades of entrepreneurial and investment expertise, with a strong emphasis on supporting underrepresented founders and female-led ventures. Medingenii’s unique blend of healthcare specialization and its commitment to diversity position it as a critical player for startups seeking to make a significant impact in the medical and health sectors.

Manifold Ventures (MMV) is a venture capital firm focused on supporting early-stage companies in healthcare innovation. Founded by physicians and healthcare entrepreneurs, MMV invests in startups that are developing groundbreaking medical technologies and solutions. The firm is known for its hands-on approach, offering more than just capital; they provide strategic guidance, operational expertise, and access to an extensive network of industry professionals. Their portfolio includes companies like Stellation (patient-provider matching technology), PocketRN (telehealth nursing), and Gradient Health (a healthcare data marketplace). MMV's team, led by Dr. Branden Rosenhan and Dr. Saumitra Thakur, brings deep experience in both clinical practice and business, which they leverage to help their portfolio companies navigate the complexities of the healthcare industry. MMV is headquartered in Salt Lake City and focuses on identifying promising healthcare innovations early in their development cycle, with the goal of helping these startups scale into successful enterprises.

MEDX Ventures Group is a Hingham, Massachusetts-based investment and management company founded in 2010 by Harel, who serves as CEO and Company Group Chairman, with offices in the US, Europe, and Israel. The firm focuses on Israeli medical technology and robotic companies, applying a proprietary 'X Model' that provides active management through dedicated Development, Regulatory, Commercial, and Finance teams embedded alongside portfolio companies throughout their lifecycle. In 2015, MEDX raised $30 million for Israeli biomed startups and established MEDX Xelerator, a leading medical-device-focused incubator operating under the auspices of the Israel Innovation Authority. MEDX Xelerator is located in Or Yehuda and Sakhnin, Israel, and partners with Boston Scientific, Sheba Medical Center, Intellectual Ventures, Consensus Business Group, West Pharmaceuticals, Wolfson Hospital, Weill Cornell Medicine Enterprise Innovation, and Ichilov Hospital. Innovation areas include vascular, interventional cardiology, urology, interventional oncology, medical robotics, and digital health solutions. MEDX leads rounds and invests at pre-seed through Series A stages. Across approximately 8 investments, the portfolio includes Microbot Medical (IPO), XACT Robotics (Harel serves as Chairman), Append Medical ($7.4 million Series A), and VeinWay (most recent seed investment, March 2023). The related Edge Medical Ventures launched a $70 million medtech fund to complement MEDX's earlier-stage activity. The MEDX model differs from conventional medtech VCs in that its team actively manages regulatory strategy, commercial development, and financing alongside founders rather than providing capital and periodic board oversight. This hands-on operational approach is designed to reduce time-to-market and de-risk regulatory submissions for hardware-intensive medical devices and robotic surgical systems.

Melitas Ventures is a New York-based venture capital fund founded in 2017 that invests in early-stage consumer companies, with a particular focus on better-for-you branded food and beverage products. The firm's name derives from the Latin 'Melius est' (better for you) and 'Opportunitas' (opportunity). Founder and Managing Partner Alex Malamatinas leads a team of 11 with additional partners including Jacques. The firm is SEC-registered as an investment adviser (#309510) and closed Fund III at $120 million. Melitas leads rounds, typically writing checks between $500,000 and $3 million at Seed and Series A stages. Across 26 portfolio companies, the firm has produced 1 unicorn — OLIPOP, the prebiotic soda brand that achieved unicorn status in 2025 — along with 3 acquisitions and 1 portfolio exit (Ampla, April 2025). Other notable portfolio companies include Magic Spoon (cereal), MUD\WTR (coffee alternative), Lemon Perfect (flavored water), Laundry Sauce, NomNomNow (pet food), Amara (baby food), Evergreen, Hanni (personal products, most recent investment October 2025), and Final Boss Sour (invested May 2025). The firm is actively expanding beyond food and beverage into personal care and beauty, where it identifies attractive unit economics in adjacent consumer categories. Melitas supports founders throughout the entire value chain — supply chain, distribution, brand strategy, digital marketing, public relations, and financial planning for profitable growth — rather than providing capital alone. This operational depth reflects the firm's conviction that consumer brand success depends on execution across every commercial touchpoint, not just product-market fit. The $120 million Fund III scale gives Melitas the capacity to lead rounds and follow portfolio companies through multiple stages of growth.

Mendoza Ventures, co-founded by Adrian and Senofer Mendoza, is a Boston and San Francisco-based venture capital firm specializing in early-stage investments in AI, cybersecurity, and fintech. The firm is known for its strong focus on diversity, with 90% of its portfolio companies led by immigrants, people of color, or women. Since its founding, Mendoza Ventures has raised three funds and supported over 15 startups, with several successful exits, including Alyce, acquired by Sendoso, and Finch, acquired by Finder. Their hands-on approach means they limit their portfolio to 12-15 companies, allowing them to dedicate significant time and resources to each startup, meeting weekly with founders to provide strategic guidance and operational support. Mendoza Ventures’ focus on diversity and inclusion, combined with their deep domain expertise in AI, fintech, and cybersecurity, positions them as leaders in driving innovation in these sectors. The firm has secured significant investments from major financial institutions, including Bank of America and Truist, underscoring their commitment to closing the wealth gap and supporting underrepresented founders.

Menlo Ventures, a Silicon Valley-based venture capital firm, has a robust history of investing in transformative technology companies across consumer, enterprise, and healthcare sectors. Notable investments include Uber, Roku, Warby Parker, Poshmark, and Chime. The firm focuses on early-stage investments but supports companies through their entire growth journey. Menlo Ventures recently closed a $1.35 billion fund aimed at backing the next generation of AI startups, reflecting its commitment to cutting-edge technologies. The firm also emphasizes deep involvement with portfolio companies, offering strategic guidance and support through every stage of development.

Mento VC is an institutional venture capital firm founded in 2023 and based in Wilmington, Delaware, investing in startups driving the future of work, automation, AI, and productivity. Founder and General Partner Alex Zhuravlev brings 14 years in technology and 8 years in venture capital, most recently as Portfolio Director at AltaIR Capital ($600 million AUM) where he oversaw more than 350 startups and supported 10 unicorns and 2 decacorns. Ekaterina serves as COO managing investor relations, capital calls, and founder support. Mento invests at pre-seed and seed stages with check sizes typically between $100,000 and $1 million, targeting teams from the United States, United Kingdom, and Israel building productivity tools, future-of-work platforms, B2B SaaS enterprise software, fintech, and HRTech. Across approximately 25 investments, the firm has built a portfolio of AI-driven companies that includes Artisan AI (digital workers for sales automation), Eragon AI ($8 million seed, December 2025 — AI operating system for enterprise), Leo AI ($5 million seed, September 2025 — AI copilot for mechanical engineering), Final Round AI (interview preparation), Clerk Chat (business text messaging), Openlayer ($14.5 million Series A, May 2025 — automated testing), sync.so, Tella, Phia, Alma, AvatarOS, Mirai Tech, and Rork (software development, April 2026). Mento's investment pace is notably active for a fund launched in 2023, reflecting Zhuravlev's thesis that the current AI cycle is producing durable productivity companies at an accelerated rate. The firm's focus on the intersection of AI, automation, and enterprise workflows across US, Israeli, and European founding teams positions it to source deals across the most active clusters of AI talent globally.

Merian Ventures is a San Francisco-based venture capital firm founded in 2015 that focuses on finding, funding, and scaling women-founded and co-founded companies in cybersecurity, blockchain, artificial intelligence, machine learning, and consumer-facing technologies. Founder and Managing Partner Alexsis de Raadt St James holds an MS from MIT and an MBA from Erasmus University. Venture Partner Priya Guha MBE is a former career diplomat who served as British Consul General to San Francisco and holds positions as a non-executive director at UKRI and member of the InnovateUK Council. The team of six includes two partners. The firm invests at Seed and Series A stages with deal sizes typically between $1 million and $5 million, targeting founding teams in the United States and United Kingdom across AI, cybersecurity, blockchain, SaaS, and software. Across 12 investments, the portfolio includes Honeycomb.io (observability platform), Provenance (supply chain transparency), AiSport (most recent investment, August 2023), Alfa (business software), and Aiwyn (financial software). One exit has been recorded: ImpactVision, acquired in February 2020. No investments have been made in 2024 or 2025, suggesting the fund may be between deployment cycles. Merian Ventures champions diversity in tech through a dedicated focus on female founders building companies at the frontier of STEM-related deep technology. The firm's transatlantic reach — combining the San Francisco technology ecosystem with a Venture Partner who brings deep UK government and innovation policy networks — gives portfolio companies access to regulatory intelligence and public sector pathways that are particularly relevant for cybersecurity and AI companies operating in regulated markets.

Meridian Street Capital is a venture capital firm established in 2016, based in New York City. The firm specializes in early-stage investments at the intersection of healthcare and technology. Their approach is to support founders from the earliest stages, often from day one, to help turn innovative ideas into category-defining companies. Meridian Street Capital has a strong portfolio that includes companies like 1upHealth, ClosedLoop.ai, and Jona Health, among others. They focus on investing in businesses that leverage technology to improve healthcare services, access, and efficiency. Typically, their investments range from $100K to $5M, with a sweet spot around $1.5M. The firm has a hands-on approach, providing strategic guidance and leveraging their industry connections to support the growth of their portfolio companies. The team at Meridian Street Capital includes key figures such as George Ribaroff and T. Scott Law Jr., who bring extensive experience in venture capital and healthcare technology. They have a focused strategy, partnering with a concentrated group of startups to ensure dedicated support and resources. Meridian Street Capital has made a total of 47 investments and has seen several successful exits, including Valify and Hint Health. Their investment strategy emphasizes backing exceptional teams with innovative solutions that have the potential to transform healthcare.

Meritus Ventures, L.P. is a $36.4 million venture capital fund formed in 2002 to make equity investments in private, expansion-stage companies in predominantly rural areas of central and southern Appalachia. The fund is a Rural Business Investment Company (RBIC) created under the USDA's Rural Business Investment Program, which promotes professionally managed venture capital in underserved rural regions. Managed by Eclipse Management LLC, the fund is led by Ray Moncrief (President and Fund Manager) and Grady Vanderhoofven (Executive Vice President and Fund Manager). The LP base includes banks and private financial institutions from the Farm Credit System, large foundations, high-net-worth individuals, the University of Kentucky, the Appalachian Regional Commission, and the Tennessee Valley Authority. Meritus leads rounds, deploying $1 million to $10 million per deal at Series A and Series B stages across information technology, industrials, and technology, media, and telecommunications companies. Geographic focus spans Tennessee, Kentucky, Arkansas, and Appalachian counties of Ohio, West Virginia, Virginia, North Carolina, South Carolina, Georgia, Alabama, and Mississippi. Across approximately 12 investments, the fund produced 4 acquisitions. The headline exit was GRIDSMART (traffic intelligence technology), which was acquired by Cubic Corporation for $87 million in January 2019. Other portfolio companies include Pinnacle Medical Solutions and Superior Fabrication. The fund is fully deployed with no new investments since 2013 and is currently in harvest mode. Meritus Ventures represents one of the more successful examples of USDA-backed rural VC, demonstrating that technology companies with scalable products and strong management can be built and exited successfully from markets that coastal venture capital historically overlooked.

Meron Capital, founded in 2017 and based in Tel Aviv, is an early-stage venture capital firm focused on investing in deep-technology software startups. The firm, led by managing partners Liron Azrielant and Daniel Roditi, has raised two funds, Meron I and Meron II, each with $50 million. Meron Capital primarily invests in sectors such as enterprise software, cybersecurity, digital health, fintech, and DevOps, targeting pre-seed and seed-stage companies. Notable investments by Meron Capital include Loom Systems, acquired by ServiceNow; Reshuffle, acquired by Twitter; Clear Genetics, acquired by Invitae; and Axonize, acquired by Planon. The firm’s current portfolio also includes promising startups like LendAI, Sorbet, Firmbase, and Laminar​. Meron Capital prides itself on a founder-first approach, providing not just capital but also strategic guidance and leveraging their extensive network to help startups scale. They emphasize backing resilient and technically proficient founders who are capable of pushing through challenges and leveraging subtle expert feedback to refine their business models​.

Merus Capital, founded in 2008 and based in Palo Alto, California, focuses on early-stage investments, primarily from pre-seed to Series A rounds. The firm specializes in sectors such as HR tech, big data and analytics, artificial intelligence and machine learning, biotech, and developer tools. Merus Capital has made 104 investments and has had 30 successful exits, including notable companies like Amplitude, Iterable, and Symphony​. Other prominent portfolio companies include Emi Labs, Censia, Moesif, and Modern Health​. Co-founded by Sean Dempsey, Salman Ullah, and Peter Hsing, Merus Capital aims to support ambitious teams that are building industry-defining platforms. The firm offers substantial follow-on capital and leverages its extensive network to help portfolio companies scale effectively​.

MESA Ventures was a New York City-based early-stage venture capital fund founded in 2012 by Mark Patricof (Founder and General Partner), Andrew Montgomery, and Jacob Brody. The firm raised a deliberately small $10 million fund concentrated on seed and Series A investments in e-commerce, advertising, media, enterprise software, and mobile technologies. MESA operated as a co-investment fund, writing $50,000 to $250,000 checks alongside established early-stage venture firms, with Patricof's personal investment sweet spot at $500,000. The firm also operated MESA+ as a boutique investment bank. Across 47 portfolio companies, MESA produced 19 acquisitions — an exit rate of approximately 40 percent that reflects disciplined selection rather than volume deployment. Notable exits include TripleLift, EasyPost, WhoWhatWear, and Gem (March 2022). Other portfolio companies include Abra and Arconex Capital, with the last recorded investment in April 2019. Sectors covered included e-commerce, media and entertainment, SaaS, software, advertising, and fintech. MESA leveraged its global network of media, entertainment, and technology relationships to provide companies with investor introductions, executive hiring support, business development connections, and marketing assistance. MESA is now permanently closed. The fund demonstrated that a small, tightly managed co-investment vehicle built around a high-quality network can produce exceptional outcomes relative to its capital base. By concentrating on sectors where the founding team had deep operating and media-industry relationships, MESA generated a return profile that made it one of the more productive micro-funds of its vintage despite its modest size.

MetaProp is the leading venture capital firm specializing in PropTech, blending physical and digital real estate innovations. Established in 2015 and headquartered in New York City, MetaProp has invested in over 150 PropTech startups, such as Attentive, Spruce, and Bowery, creating significant enterprise value across a 20 billion square foot real estate portfolio. MetaProp's primary investment focus is on early-stage PropTech companies that offer software, IoT, and tech-enabled services. The firm’s geographic reach is global, with notable partners across North America, Asia, and Europe. MetaProp’s investment strategy emphasizes hands-on support, providing startups with mentorship, strategic advice, and industry connections. The firm’s average investment ranges between $150,000 to $2 million, and they are known for leading investment rounds. Key team members include co-founders Aaron Block and Zak Schwarzman, who bring a wealth of experience and deep industry connections. The team is complemented by executives like Maureen Waters and Monica O’Neill, who bolster MetaProp’s commitment to supporting their portfolio companies. To engage with MetaProp, startups are encouraged to leverage their extensive network and proactive approach by pitching through their formal channels or connecting at industry events. MetaProp's accelerator program at Columbia University and other global initiatives further highlight their dedication to fostering innovation in the real estate sector.

Metrodora Ventures is a New York-based venture capital firm founded in 2020 by Chelsea Clinton. The firm focuses on early-stage investments in the health and learning sectors, with a mission to support companies that improve access to care, education, and vital information. Metrodora Ventures is driven by a values-conscious approach, investing in purpose-driven startups that aim to make a significant impact on society. The firm’s portfolio includes innovative companies like Teal Health, which is developing telehealth platforms focused on women’s health, and Blooming Health, which creates technology to help older adults maintain connections with their communities. Another notable investment is Swing Therapeutics, which develops digital therapies for chronic illness management. Metrodora Ventures operates with the goal of nurturing its portfolio companies by providing capital, market insights, and industry relationships. The firm raised its debut fund of $20.8 million and is currently in the process of raising a second fund to continue its mission of fostering impactful startups.

Noshaq is an investment fund based in Liège, Belgium, that offers a range of financing solutions aimed at fostering the creation and growth of companies, particularly SMEs. Established in 1985 under the name Meusinvest, the organization has grown significantly and rebranded to Noshaq in 2019 to better reflect its innovative and dynamic approach to investment. Noshaq manages a portfolio of 477 companies and has supported over 1,020 companies since its inception. The fund's primary focus areas include biotechnology, industry 4.0, digital technology, quality food, real estate, energy, sustainable development, and cultural industries. They provide funding through various vehicles, including equity investments, loans, and leasing, tailored to the specific needs of each stage of a company's development. Notable initiatives under Noshaq include Noshaq Spin-Offs, which supports the creation of spin-offs in collaboration with the University of Liège, and LeanSquare, which focuses on innovative projects in cultural and creative industries, enterprise software, and life sciences. Additionally, Noshaq is actively involved in regional development projects, such as La Grand Poste, a creative hub in the heart of Liège.

Meyer Ventures LLC is a New York City-based early-stage venture capital firm and the investment arm of Ocean Road Advisors, Inc., a family office managing more than $750 million in assets. The family office was founded in 2005 to oversee the assets of Edward H. Meyer, the former longstanding Chairman, President, and CEO of Grey Global Group, one of the world's largest advertising and media companies. Anthony E. Meyer serves as CEO of Meyer Ventures, President of Ocean Road Advisors, and Chairman of Meyer and Co. LLC, a merchant banking firm. The firm incubates and sponsors new ventures, invests in early-stage companies, and provides growth capital, strategic management, and financial advisory services, typically writing checks between $500,000 and $3 million at Seed and Series A stages and leading rounds. Focus areas include marketing and media, healthcare, education, and financial services. Across 26 investments with 7 recorded exits, the portfolio includes Volastra Therapeutics (Series A, March 2023 — most recent investment), Graduation Alliance (formerly The American Academy, an online education and corporate training company founded by Anthony Meyer in 2007 and sold to a PE impact fund in early 2020), and Critical Mention (most recent exit, May 2022). Meyer Ventures draws on the family's deep operating heritage in advertising and media — Grey Global Group's legacy — to identify and support founders building companies at the intersection of marketing, health, and education technology. The family office structure enables patient capital deployment without the return-driven timeline pressures of a conventional institutional fund.